172 related articles for article (PubMed ID: 26759644)
1. Outcomes of Patients Requiring Blood Pressure Control Before Thrombolysis with tPA for Acute Ischemic Stroke.
Darger B; Gonzales N; Banuelos RC; Peng H; Radecki RP; Doshi PB
West J Emerg Med; 2015 Dec; 16(7):1002-6. PubMed ID: 26759644
[TBL] [Abstract][Full Text] [Related]
2. Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke.
Martin-Schild S; Hallevi H; Albright KC; Khaja AM; Barreto AD; Gonzales NR; Grotta JC; Savitz SI
Arch Neurol; 2008 Sep; 65(9):1174-8. PubMed ID: 18779419
[TBL] [Abstract][Full Text] [Related]
3. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
[TBL] [Abstract][Full Text] [Related]
4. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
5. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
6. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
Saposnik G; Reeves MJ; Johnston SC; Bath PM; Ovbiagele B;
Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
[TBL] [Abstract][Full Text] [Related]
7. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).
Ahmed N; Wahlgren N; Brainin M; Castillo J; Ford GA; Kaste M; Lees KR; Toni D;
Stroke; 2009 Jul; 40(7):2442-9. PubMed ID: 19461022
[TBL] [Abstract][Full Text] [Related]
8. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
Rusanen H; Saarinen JT; Sillanpää N
Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943
[TBL] [Abstract][Full Text] [Related]
9. The effect of physiologic derangement in patients with stroke treated with thrombolysis.
Idicula TT; Waje-Andreassen U; Brogger J; Naess H; Lundstadsveen MT; Thomassen L
J Stroke Cerebrovasc Dis; 2008; 17(3):141-6. PubMed ID: 18436155
[TBL] [Abstract][Full Text] [Related]
10. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
11. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke.
Mokin M; Kass-Hout T; Kass-Hout O; Zivadinov R; Mehta B
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):852-9. PubMed ID: 21703878
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial.
Minhas JS; Wang X; Lindley RI; Delcourt C; Song L; Woodward M; Lee TH; Broderick JP; Pontes-Neto OM; Kim JS; Ricci S; Lavados PM; Bath PM; Durham AC; Wang JG; Sharma VK; Demchuk AM; Martins SO; Chalmers J; Anderson CS; Robinson TG;
J Hypertens; 2021 Feb; 39(2):280-285. PubMed ID: 33031175
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
[TBL] [Abstract][Full Text] [Related]
15. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
[TBL] [Abstract][Full Text] [Related]
17. Exclusion of Isolated Cortical Swelling Can Increase Efficacy of Baseline Alberta Stroke Program Early CT Score in the Prediction of Prognosis in Acute Ischemic Stroke Patients Treated with Thrombolysis.
Naito T; Takeuchi S; Arai N
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2754-8. PubMed ID: 26460245
[TBL] [Abstract][Full Text] [Related]
18. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
[TBL] [Abstract][Full Text] [Related]
19. A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients.
Smadja D; Chausson N; Joux J; Saint-Vil M; Signaté A; Edimonana M; Jeannin S; Bartoli B; Aveillan M; Cabre P; Olindo S
Stroke; 2011 Jun; 42(6):1644-7. PubMed ID: 21527758
[TBL] [Abstract][Full Text] [Related]
20. Rehabilitation outcomes of stroke patients treated with tissue plasminogen activator.
Meiner Z; Sajin A; Schwartz I; Tsenter J; Yovchev I; Eichel R; Ben-Hur T; Leker RR
PM R; 2010 Aug; 2(8):698-702; quiz 792. PubMed ID: 20709299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
